Non-Surgical Management of BPH: An Updated Review of Current Literature and State of the Art on Natural Compounds and Medical Therapy

The review highlights that benign prostatic hyperplasia (BPH) is commonly managed through medical therapy, which is preferred over surgical options due to its less invasive nature. The study analyzed 17 randomized clinical trials and 75 additional studies, focusing on various drug treatments such as phytotherapy, alpha-blockers, muscarinic receptor antagonists, and 5-alpha-reductase inhibitors. The conclusion emphasizes the importance of personalizing treatment to align with individual patient needs and preferences, as the range of therapeutic options is broad and diverse. This personalized approach is crucial for ensuring effective treatment outcomes and meeting patient expectations.